News
When it comes to getting the most out of a vaccine, arm consistency can make a difference. Some studies suggest that getting ...
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
Banning mRNA technology in response to the many missteps of public health officials during the pandemic is a textbook example ...
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
The vaccine is the only protein-based COVID shot still in use in the U.S. This approval would allow the vaccine to stay on ...
America faces a brewing public health threat as vaccination rates continue to slide downward. Diseases once eliminated ...
Novavax has been available since 2022 through a pandemic-era Emergency Use Authorization. A decision on full approval – which ...
Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
Father-of-three James Giddings has a rare allergy to a chemical so common it is in everything from soap and shaving gel to shampoo, toothpaste and even the coating on ibuprofen tablets.
The COVID-19 vaccine continues to save lives, proving the vaccination strategy paid off and was a worthwhile national ...
MDV: Multidose vial; NA: Not available ... influenza vaccination campaign estimated that the total time to get a vaccine ready to be administered per patient was 87 s for MDVs and 49.71 s for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results